Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data

This study showed that both medications significantly changed the HFSME and RULM after 3 and 6 months of follow-up. However, there was no significant difference between the two drugs according to the HFSME.

Authors

Institutions

Publication Details

Journal
Journal of Neuromuscular Diseases
Published
2024-11-01
DOI
https://doi.org/10.1177/22143602241288087
Citations
7
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
3.07
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data

Morteza Heidari, Hadi Montazerlotfelahi, Gholamreza Zamani Ghaletaki, Narjes Jafari et al.
7 citations
Journal of Neuromuscular Diseases
Neurogenetic and Muscular Disorders Research
3.07
article

Comparative efficacy of risdiplam and nusinersen in Type 2 and 3 spinal muscular atrophy patients: A cohort study using real-world data

Morteza Heidari, Hadi Montazerlotfelahi, Gholamreza Zamani Ghaletaki, Narjes Jafari, Ali Akbar Momen, Seyed Saeed Hashemi Nazari, Mehran Beiraghi Toosi, Ali Khajeh, Marzieh Babaee, Sara Memarian, Shahriar Nafissi, Mahmoud Reza Ashrafi, Mohsen Mollamohammadi, Alireza Abdi, Hassan Bakhtiary, Hossein Farshadmoghadam, Farzad Fatehi, Azita Tavasoli, Bentolhoda Ziaadini, Soroor Inaloo, Masood Ghahvechi Akbari, Mohammad Mehdi Nasehi, Reza Shervin Badv, Vahid Aminzadeh, Sedighe Nikbakht, Seyed Ahmad Hosseini, Meisam Babaei, Ramin Heshmat, Mohammad Barzegar, Mohammadreza Ghazavi, Fakhreddin Shariatmadari, Mohammad Mehdi Taghdiri, Ali Abbaskhanian, Seyyed Mohammad Mahdi Hosseiny
article en
7 citations

Abstract

This study showed that both medications significantly changed the HFSME and RULM after 3 and 6 months of follow-up. However, there was no significant difference between the two drugs according to the HFSME.

Journal of Neuromuscular DiseasesVol. 11(6)
Hamedan University of Medical Sciences (IR), Isfahan University of Medical Sciences (IR), Zanjan University of Medical Sciences (IR), Ahvaz Jundishapur University of Medical Sciences (IR), Arak University of Medical Sciences (IR), Iran University of Medical Sciences (IR), Tabriz University of Medical Sciences (IR), Mashhad University of Medical Sciences (IR), Shiraz University of Medical Sciences (IR), Guilan University of Medical Sciences (IR), Kerman University of Medical Sciences (IR), Lorestan University of Medical Sciences (IR), Urmia University (IR), Sina Hospital (IR), Children's Medical Center (IR), Golestan University of Medical Sciences (IR), Stem Cell Technology Research Center (IR), Zahedan University of Medical Sciences (IR), North Khorasan University of Medical Sciences (IR), Alborz University of Medical Sciences (IR), Urmia University of Medical Sciences (IR), Shahid Beheshti University of Medical Sciences (IR), Qom University of Medical Science and Health Services (IR), Qazvin University of Medical Sciences (IR), Tehran University of Medical Sciences (IR), Mazandaran University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 8%
Neurogenetic and Muscular Disorders Research
3.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.